176 related articles for article (PubMed ID: 12410087)
1. Clinical outcomes in juvenile dermatomyositis.
Ramanan AV; Feldman BM
Curr Opin Rheumatol; 2002 Nov; 14(6):658-62. PubMed ID: 12410087
[TBL] [Abstract][Full Text] [Related]
2. Lipodystrophy and metabolic abnormalities in a case of adult dermatomyositis.
Lee LA; Hobbs KF
J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S85-7. PubMed ID: 17938031
[TBL] [Abstract][Full Text] [Related]
3. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
Wang A; Morgan GA; Paller AS; Pachman LM
J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
[TBL] [Abstract][Full Text] [Related]
4. Juvenile dermatomyositis.
Batthish M; Feldman BM
Curr Rheumatol Rep; 2011 Jun; 13(3):216-24. PubMed ID: 21312074
[TBL] [Abstract][Full Text] [Related]
5. Juvenile dermatomyositis: clinical profile and disease course in 25 patients.
Shehata R; al-Mayouf S; al-Dalaan A; al-Mazaid A; al-Balaa S; Bahabri S
Clin Exp Rheumatol; 1999; 17(1):115-8. PubMed ID: 10084045
[TBL] [Abstract][Full Text] [Related]
6. Improvement of nailfold capillary microangiopathy after immunosuppressant therapy in a child with clinically amyopathic juvenile dermatomyositis.
Campos LMA; Sallum AME; Camargo CZ; Andrade LEC; Kayser C
Rev Bras Reumatol Engl Ed; 2017; 57(5):487-490. PubMed ID: 29037322
[No Abstract] [Full Text] [Related]
7. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
Fisler RE; Liang MG; Fuhlbrigge RC; Yalcindag A; Sundel RP
J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of probenecid for a patient with juvenile dermatomyositis complicated with calcinosis.
Nakamura H; Kawakami A; Ida H; Ejima E; Origuchi T; Eguchi K
J Rheumatol; 2006 Aug; 33(8):1691-3. PubMed ID: 16881125
[TBL] [Abstract][Full Text] [Related]
9. Successful immunosuppressive treatment of dermatomyositis: a nailfold capillaroscopy survey.
Riccieri V; Vasile M; Macri V; Sciarra I; Stefanantoni K; De Luca N; Di Franco M; Spadaro A
J Rheumatol; 2010 Feb; 37(2):443-5. PubMed ID: 20147478
[No Abstract] [Full Text] [Related]
10. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].
Constantin T; Ponyi A; Kálovics T; Orbán I; Molnár K; Dérfalvy B; Dicso F; Sallai A; Garami M; Balogh Z; Szalai Z; Fekete G; Dankó K
Orv Hetil; 2007 Oct; 148(42):1989-97. PubMed ID: 17932005
[TBL] [Abstract][Full Text] [Related]
11. Juvenile dermatomyositis forty years on: Case report.
Rego de Figueiredo I; Guerreiro Castro S; Bernardino V; Silva Nunes J; Alves P; Moraes-Fontes MF
Neuromuscul Disord; 2018 Sep; 28(9):791-797. PubMed ID: 30064892
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
Ogimi C; Honma N; Tanaka R; Oh-ishi T
Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
[TBL] [Abstract][Full Text] [Related]
13. [Two children with skin rash and muscle weakness: juvenile dermatomyositis].
Boogaard R; Drexhage VR; van Suijlekom-Smit LW
Ned Tijdschr Geneeskd; 2005 Jan; 149(3):146-50. PubMed ID: 15693592
[TBL] [Abstract][Full Text] [Related]
14. An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis.
Kavala M; Sudogan S; Can B; Zindanci I; Kuru I; Beyhan S; Kocaturk E
Clin Exp Dermatol; 2009 Jan; 34(1):115-6. PubMed ID: 19076816
[No Abstract] [Full Text] [Related]
15. Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis.
Ostrowski RA; Sullivan CL; Seshadri R; Morgan GA; Pachman LM
Arthritis Rheum; 2010 May; 62(5):1533-8. PubMed ID: 20213809
[TBL] [Abstract][Full Text] [Related]
16. Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis.
Arabshahi B; Silverman RA; Jones OY; Rider LG
J Pediatr; 2012 Mar; 160(3):520-2. PubMed ID: 22244459
[TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis update.
Lindsley CB
Curr Rheumatol Rep; 2006 Jun; 8(3):174-7. PubMed ID: 16901074
[TBL] [Abstract][Full Text] [Related]
18. Ten-year experience of juvenile dermatomyositis: a retrospective study.
Chiu SK; Yang YH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
[TBL] [Abstract][Full Text] [Related]
19. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
Kim S; El-Hallak M; Dedeoglu F; Zurakowski D; Fuhlbrigge RC; Sundel RP
Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
[TBL] [Abstract][Full Text] [Related]
20. Twelve years experience of juvenile dermatomyositis in North India.
Singh S; Bansal A
Rheumatol Int; 2006 Apr; 26(6):510-5. PubMed ID: 16163542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
